Ebola virus vaccine trials: The ethical mandate for a therapeutic safety net

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Bellan, Steve E ^a   Pulliam, Juliet R C ^b   Dushoff, Jonathan ^c   Meyers, Lauren Ancel ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

AGE DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; EBOLA HEMORRHAGIC FEVER; EQUIPOISE; HEALTH CARE ACCESS; HUMAN; INTENSIVE CARE; LETTER; MEDICAL ETHICS; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; SURVIVAL RATE; ADOLESCENT; ADULT; ETHICS; HEMORRHAGIC FEVER, EBOLA; PATIENT SAFETY; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; EBOLA VACCINES; HEMORRHAGIC FEVER, EBOLA; HUMANS; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84915749446     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g7518     Document Type: Letter

References (9)

1. Arie S. Ebola: an opportunity for a clinical trial? BMJ 2014;349:g4997. (6 August.)
2. Van der Graaf R, van Delden JJM. Equipoise should be amended, not abandoned. Clin Trials 2011;8:408-16.
3. Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan A, Delfraissy JF, et al. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014;384:1423-4.
4. Cohen J, Kupferschmidt K. Tough choices ahead in Ebola vaccine trials. ScienceMag 2014. http://news.sciencemag.org/africa/2014/10/tough-choices-ahead-ebola-vaccine-trials.
5. Bah EI, Lamah M-C, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2014; published online 5 Nov; doi:10.1056/NEJMoa1411249.
6. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014;371:2092-100.
7. WHO Ebola Response Team, Ebola virus disease in west Africa - the first 9 months of the epidemic and forward projections. N Engl J Med 2014;371:1481-95.
8. Angell M. The ethics of clinical research in the third world. N Engl J Med 1997;337:847-9.
9. GSK. Proposed phase 2 program for ChAd3 EBOV vaccine candidate. WHO consultation. www.who.int/entity/immunization/diseases/ebola/GSK-Phase-2-Program-WHO-29-30-Sep-2014.pdf.